Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
17/03/2023 13:14
March 17 (Reuters) - Pure Biologics SA PUR1.WA :
* SIGNS TERM SHEET WITH ACRX INVESTMENTS ON POTENTIAL
FINANCING
* GAINED FUNDS WILL BE USED TOWARDS RESEARCH AND DEVELOPMENT
WORKS
* UNDER TERM SHEET, ACRX TO GRANT COMPANY LOAN CONVERTIBLE
TO
NEWLY-ISSUED CO'S SHARES
* LOAN WILL BE NO LESS THAN 12 MILLION ZLOTYS
* PARTIES INTEND TO SIGN INVESTMENT DEAL BY APRIL 30
Source text for Eikon: ID:nEMzSXqba
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects